MYBL2 and cancer: Meanwhile, MYBL2 amplification or overexpression has been observed in cancers such as myeloid leukemias (AML) [8], hepatocellular carcinoma [9], breast cancer [10], and it is currently used as a marker for poor prognosis in colorectal carcinoma [11].